Jefferies Group's TMCI Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 26,591 shares of Treace Medical Concepts, Inc. (TMCI) worth $105,833, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in TMCI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Treace Medical Concepts (TMCI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Treace Medical Concepts (TMCI) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +26,591 | New Buy | 26,591 | $3.98 |
Jefferies Group's Treace Medical Concepts Investment FAQs
Jefferies Group first purchased Treace Medical Concepts, Inc. (TMCI) in Q2 2026, acquiring 26,591 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Treace Medical Concepts, Inc. (TMCI) for 1 quarters since Q2 2026.
Jefferies Group's largest addition to Treace Medical Concepts, Inc. (TMCI) was in Q2 2026, adding 26,591 shares worth $105,833.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 26,591 shares of Treace Medical Concepts, Inc. (TMCI), valued at approximately $105,833.
As of the Q2 2026 filing, Treace Medical Concepts, Inc. (TMCI) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Treace Medical Concepts, Inc. (TMCI) was 26,591 shares, as reported at the end of Q2 2026.